Valeant Pharmaceuticals North America LLC et al v. Mylan Pharmaceuticals Inc. et al

Plaintiff: Kaken Pharmaceutical Co. Ltd., Dow Pharmaceutical Sciences, Inc., Valeant Pharmaceuticals North America LLC and Valeant Pharmaceuticals Ireland Ltd.
Defendant: Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan Laboratories Ltd.
Case Number: 1:2018cv00184
Filed: September 27, 2018
Court: US District Court for the Northern District of West Virginia
Presiding Judge: Irene M Keeley
Nature of Suit: Patent
Cause of Action: 35:271
Jury Demanded By: None

Docket Report

This docket was last retrieved on October 26, 2018. A more recent docket listing may be available from PACER.

Date Filed Document Text
October 26, 2018 Opinion or Order Filing 15 ORDER granting #9 Motion for Paul M. Schoenhard to Appear Pro Hac Vice on behalf of the Plaintiffs. Signed by Senior Judge Irene M. Keeley on 10/26/18. (mh)
October 26, 2018 Opinion or Order Filing 14 ORDER granting #10 Motion for Nicole M. Jantzi to Appear Pro Hac Vice on behalf of the Plaintiffs. Signed by Senior Judge Irene M. Keeley on 10/26/18. (mh)
October 26, 2018 Opinion or Order Filing 13 ORDER granting #8 Motion for Thomas P. Steindler to Appear Pro Hac Vice on behalf of the Plaintiffs. Signed by Senior Judge Irene M. Keeley on 10/26/18. (mh)
October 26, 2018 Opinion or Order Filing 12 ORDER granting #7 Motion for Ian B. Brooks to Appear Pro Hac Vice on behalf of the Plaintiffs. Signed by Senior Judge Irene M. Keeley on 10/26/18. (mh)
October 24, 2018 Filing 11 Pro Hac Vice Filing fee: $ 800.00, receipt number WVNC002387. (jmm)
October 23, 2018 Filing 10 MOTION for Leave to Appear Pro Hac Vice of Nicole M. Jantzi by Dow Pharmaceutical Sciences, Inc., Kaken Pharmaceutical Co. Ltd., Valeant Pharmaceuticals Ireland Ltd., Valeant Pharmaceuticals North America LLC. (Attachments: #1 Text of Proposed Order)(Companion, James)
October 23, 2018 Filing 9 MOTION for Leave to Appear Pro Hac Vice of Paul M. Schoenhard by Dow Pharmaceutical Sciences, Inc., Kaken Pharmaceutical Co. Ltd., Valeant Pharmaceuticals Ireland Ltd., Valeant Pharmaceuticals North America LLC. (Attachments: #1 Text of Proposed Order)(Companion, James)
October 23, 2018 Filing 8 MOTION for Leave to Appear Pro Hac Vice of Thomas P. Steindler by Dow Pharmaceutical Sciences, Inc., Kaken Pharmaceutical Co. Ltd., Valeant Pharmaceuticals Ireland Ltd., Valeant Pharmaceuticals North America LLC. (Attachments: #1 Text of Proposed Order)(Companion, James)
October 23, 2018 Filing 7 MOTION for Leave to Appear Pro Hac Vice of Ian B. Brooks by Dow Pharmaceutical Sciences, Inc., Kaken Pharmaceutical Co. Ltd., Valeant Pharmaceuticals Ireland Ltd., Valeant Pharmaceuticals North America LLC. (Attachments: #1 Text of Proposed Order)(Companion, James)
September 27, 2018 Filing 6 REPORT to USPTO on the filing or determination of an action regarding re #1 Complaint. (mh)
September 27, 2018 Filing 5 REPORT to USPTO on the filing or determination of an action regarding re #1 Complaint. (mh)
September 27, 2018 Filing 4 Filing fee: $ 400.00, receipt number WVNW001991 (mh)
September 27, 2018 Filing 3 SUPPLEMENTAL INFORMATION FOR PATENT CASES INVOLVING AN ABBREVIATED NEW DRUG APPLICATION (ANDA) filed by Dow Pharmaceutical Sciences, Inc., Kaken Pharmaceutical Co. Ltd., Valeant Pharmaceuticals Ireland Ltd., Valeant Pharmaceuticals North America LLC. (mh)
September 27, 2018 Filing 2 Corporate Disclosure Statement by Dow Pharmaceutical Sciences, Inc., Kaken Pharmaceutical Co. Ltd., Valeant Pharmaceuticals Ireland Ltd., Valeant Pharmaceuticals North America LLC identifying Corporate Parent Bausch Health Companies Inc. for Dow Pharmaceutical Sciences, Inc., Valeant Pharmaceuticals Ireland Ltd. and Valeant Pharmaceuticals North America LLC. (mh)
September 27, 2018 Filing 1 COMPLAINT against Mylan Inc., Mylan Laboratories Ltd. and Mylan Pharmaceuticals Inc., filed by Valeant Pharmaceuticals North America LLC, Valeant Pharmaceuticals Ireland Ltd., Kaken Pharmaceutical Co. Ltd., Dow Pharmaceutical Sciences, Inc. (Attachments: #1 Exhibit A - Patent Information, #2 Exhibit B - Patent Information, #3 Exhibit C - Patent Information, #4 Exhibit D - Patent Information, #5 Exhibit E - Patent Information, #6 Exhibit F - Patent Information, #7 Exhibit G - Patent Information, #8 Exhibit H - Patent Information, #9 Civil Cover Sheet)(mh)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the West Virginia Northern District Court's Electronic Court Filings (ECF) System

Search for this case: Valeant Pharmaceuticals North America LLC et al v. Mylan Pharmaceuticals Inc. et al
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Kaken Pharmaceutical Co. Ltd.
Represented By: James F. Companion
Represented By: Paul M. Schoenhard
Represented By: Ian B. Brooks
Represented By: Nicole M. Jantzi
Represented By: Thomas P. Steindler
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Dow Pharmaceutical Sciences, Inc.
Represented By: James F. Companion
Represented By: Paul M. Schoenhard
Represented By: Ian B. Brooks
Represented By: Nicole M. Jantzi
Represented By: Thomas P. Steindler
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Valeant Pharmaceuticals North America LLC
Represented By: James F. Companion
Represented By: Paul M. Schoenhard
Represented By: Ian B. Brooks
Represented By: Nicole M. Jantzi
Represented By: Thomas P. Steindler
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Valeant Pharmaceuticals Ireland Ltd.
Represented By: James F. Companion
Represented By: Paul M. Schoenhard
Represented By: Ian B. Brooks
Represented By: Nicole M. Jantzi
Represented By: Thomas P. Steindler
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Mylan Pharmaceuticals Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Mylan Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Mylan Laboratories Ltd.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?